Changes in the Serum Proteome of Patients with Sepsis and Septic Shock

Sepsis is still the leading cause of death in the intensive care unit. Our goal was to elucidate potential early differences in serum between survivors (SURV) and non-survivors (NON-SURV) on day 28. We applied proteomic technology to serum samples of patients with sepsis and septic shock. Serum samp...

Full description

Saved in:
Bibliographic Details
Published inAnesthesia and analgesia Vol. 103; no. 6; pp. 1522 - 1526
Main Authors Kalenka, Armin, Feldmann, Robert E., Otero, Kevin, Maurer, Martin H., Waschke, Klaus F., Fiedler, Fritz
Format Journal Article
LanguageEnglish
Published Hagerstown, MD International Anesthesia Research Society 01.12.2006
Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Sepsis is still the leading cause of death in the intensive care unit. Our goal was to elucidate potential early differences in serum between survivors (SURV) and non-survivors (NON-SURV) on day 28. We applied proteomic technology to serum samples of patients with sepsis and septic shock. Serum samples from 18 patients with sepsis and septic shock were obtained during the first 12 h after diagnosis of septic shock. Patients were grouped into SURV and NON-SURV on day 28. Seven patients survived and 11 patients died. Using proteome analysis, two-dimensional gel electrophoresis detected more than 200 spots per gel. A differential protein expression was discovered between SURV and NON-SURV, whereby protein alterations not yet described in sepsis were revealed. Our results show that proteomic profiling is a useful approach for detecting protein expression dynamics in septic patients, and may bring us closer to achieving a comprehensive molecular profiling compared with genetic studies alone.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0003-2999
1526-7598
DOI:10.1213/01.ane.0000242533.59457.70